Molly Stevens has been Appointed Dame Commander of the Most Excellent Order of the British Empire (DBE) for Services to Medicine
Molly Stevens has been Appointed Dame Commander of the Most Excellent Order of the British Empire (DBE) for Services to Medicine
We are incredibly proud that Kavli Oxford's Co-Deputy Director, Professor Molly Stevens, John Black Professor of Bionanoscience has been appointed Dame Commander of the Most Excellent Order of the British Empire (DBE) for services to Medicine.
The New Year Honours 2024 Lists have been published, acknowledging the achievements and service of exceptional individuals across the UK, including members of the University of Oxford. We are pleased to announce that Molly Stevens, Co-Deputy Director at Kavli Oxford, is among the honorees.
Professor Molly Stevens FRS FREng, John Black Professor of Bionanoscience at the Department of Physiology, Anatomy & Genetics and the Institute of Biomedical Engineering, has been appointed Dame Commander of the Most Excellent Order of the British Empire (DBE) for services to Medicine.
Professor Stevens obtained her PhD at the University of Nottingham, did her postdoctoral research at the Massachusetts Institute of Technology (MIT), and led a highly interdisciplinary research programme at Imperial College London from 2004-2023 where she still holds a part-time position. She has won 40 awards, including the Novo Nordisk Award in 2023, the MRS Mid-Career Researcher Award in 2022, and the American Chemical Society Award in Colloid Chemistry in 2020.
Professor Stevens is a Fellow of eight Professional Bodies, including The Royal Society (FRS) and Royal Academy of Engineering (FREng), and is also a Foreign Member of the National Academy of Engineering and an International Honorary Member of the American Academy of Arts and Sciences.
Professor Stevens said: ‘I would like to thank my incredible team of researchers and staff who inspire me every day towards the mission of transforming healthcare through biomaterials technologies. All the advances that we have made into the design of new biosensing, therapeutics and regenerative medicine technologies are the result of strong teamwork both inside the lab and through to our external collaborators and key industrial partners. A key focus has been, and will continue to be, designing effective yet accessible technologies that can help in democratising access to healthcare.’
Since April 2021, Oxford University's KAVLI Institute for Nanoscience Discovery is proudly serving as a hub for research groups from seven different departments spanning both the medical and physical sciences, including the Stevens Group from the Department of Physiology, Anatomy & Genetics.
